Werewolf Therapeutics, Inc. Common Stock HOWL
i
Market datapartial · fetched 2026-11-13T18:33:57.740Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-04-16
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T18:14:39.619676082Z
FundamentalsAlpha Vantage · unavailable
Werewolf Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | 1.41 | 147.5% | 66.6% | |||
| 60Δ | 1.31 | 161.0% | 62.1% | 1.96 | 131.9% | 12.2% |
| 65Δ | 1.20 | 174.4% | 57.6% | 2.68 | 158.9% | 10.2% |
| 70Δ | 1.10 | 187.9% | 53.1% | 3.71 | 170.5% | 6.1% |
| 75Δ | 1.00 | 201.4% | 48.6% | |||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 1.41
- IV
- 147.5%
- B/E move
- 66.6%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 1.31
- IV
- 161.0%
- B/E move
- 62.1%
- Pseudo strike
- 1.96
- IV
- 131.9%
- B/E move
- 12.2%
65Δ
- Pseudo strike
- 1.20
- IV
- 174.4%
- B/E move
- 57.6%
- Pseudo strike
- 2.68
- IV
- 158.9%
- B/E move
- 10.2%
70Δ
- Pseudo strike
- 1.10
- IV
- 187.9%
- B/E move
- 53.1%
- Pseudo strike
- 3.71
- IV
- 170.5%
- B/E move
- 6.1%
75Δ
- Pseudo strike
- 1.00
- IV
- 201.4%
- B/E move
- 48.6%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 242.07% | |
| 233.87% | |
| 264.98% | |
| 248.75% | |
| 386.20% | |
| 245.07% | |
| 223.11% | |
| 226.34% | |
| 263.15% | |
| 296.30% | |
| 195.77% | |
| 267.70% | |
| 272.27% | |
| 286.21% | |
| 168.37% | |
| 305.79% | |
| 278.38% | |
| 233.88% | |
| 289.28% | |
| 279.05% | |
| 297.09% |
Biotechnology
HRMY
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is…
More →HUMA
Humacyte Inc (HUMA) is a groundbreaking biotechnology firm at the forefront of vascular and regenerative medicine, specializing in the development of human acellular vessels…
More →IBRX
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
More →IDYA
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected…
More →IFRX
Description unavailable
More →IGC
India Globalization Capital, Inc. buys and resells physical infrastructure commodities. The company is headquartered in Potomac, Maryland.
More →